SSR150106XB
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SSR150106XB, covering 2017-08-08 to 2017-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis [Phase 2]